Pharmaceutical advances offer new options for health outcomes
Research presented at Digestive Disease Week (DDW) explores pharmaceutical advances for treating irritable bowel syndrome with diarrhea (IBS-D) and hepatitis C.
Diseases, Conditions, Syndromes
May 20, 2013 |
not rated yet |
0
PARP inhibitor shows activity in pancreatic, prostate cancers among patients carrying BRCA mutations
In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced ...
Cancer
May 15, 2013 |
not rated yet |
0
Nearly 5 million asthmatics could benefit from antifungal therapy
An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers from The University of Manchester and the University of Toronto.
Inflammatory disorders
May 08, 2013 |
not rated yet |
0
Study demonstrates that once-a-day pill offers relief from ragweed allergy symptoms
An international team of researchers, led by physician-scientists at Johns Hopkins, reports that a once-daily tablet containing a high dose of a key ragweed pollen protein effectively blocks the runny noses, sneezes, nasal ...
Immunology
May 07, 2013 |
not rated yet |
0
Novel anti-clotting drug more effective than Plavix in coronary procedures, study says
(Medical Xpress)—An experimental drug has been shown to be significantly more effective at preventing blood clots during coronary stenting procedures compared to the anti-clotting agent now typically used, according to ...
Cardiology
Mar 11, 2013 |
not rated yet |
0
|
Kala-azar treatment failing in Nepal
In a recent study, scientists have concluded that the cure rates of Miltefosine, the only oral drug for visceral leishmaniasis available, have significantly decreased. Miltefosine was introduced in the Indian subcontinent ...
Diseases, Conditions, Syndromes
Mar 01, 2013 |
not rated yet |
0
Newer, shorter-course antibiotic shows similar effectiveness for treating skin infection
Treatment with a newer antibiotic, tedizolid phosphate, once daily for 6 days was statistically noninferior (no worse than) in efficacy to the antibiotic linezolid twice daily for 10 days for both early (at day 2 to 3) and ...
Diseases, Conditions, Syndromes
Feb 12, 2013 |
not rated yet |
0
Tenofovir Gel wins out in drug absorption study, but HIV prevention trials say differently
A novel head-to-head study looking at differences in how the antiretroviral (ARV) drug tenofovir gets absorbed in the body as either an oral tablet or a vaginal gel found tenofovir gel can achieve substantially higher concentrations ...
HIV & AIDS
Jan 30, 2013 |
not rated yet |
0
First oral drug for spinal cord injury improves movement in mice
An experimental oral drug given to mice after a spinal cord injury was effective at improving limb movement after the injury, a new study shows.
Neuroscience
Jan 08, 2013 |
5 / 5 (7) |
0
|
Innovative method to deliver THC: Transmucosal patch increases drug's absorption
(Medical Xpress)—An innovative delivery method for tetrahydrocannabinol, the main psychoactive constituent of Cannabis, is being developed at the University of Mississippi.
Medications
Dec 20, 2012 |
not rated yet |
0
Risk of blood clots two-fold for women with polycystic ovary syndrome on combined pill
Women with polycystic ovary syndrome (PCOS) who are taking combined oral contraceptives have a 2-fold risk of blood clots compared with women without the disorder who take contraceptives, states a study published in CMAJ (Canad ...
Medications
Dec 03, 2012 |
not rated yet |
0
Clinical trial delivers good results in leukemia patients
Huntsman Cancer Institute (HCI) researchers Michael Deininger, M.D., Ph.D., and Thomas O'Hare, Ph.D., were part of a team that found a potent oral drug, ponatinib, effective in patients who have developed resistance to standard ...
Cancer
Nov 30, 2012 |
not rated yet |
0
New drug overcomes resistance in patients with rare sarcoma
A new targeted drug demonstrated its ability to control metastatic gastrointestinal stromal tumor, an uncommon and life-threatening form of sarcoma, after the disease had become resistant to all existing therapies, report ...
Cancer
Nov 21, 2012 |
5 / 5 (1) |
0
|
Treatment for snail-borne schistosomiasis works best over the long haul
Watch where you jump in for a swim or where your bath water comes from, especially if you live in Africa, Asia or South America. Snails that live in tropical freshwater in these locations are intermediaries ...
Diseases, Conditions, Syndromes
Nov 20, 2012 |
not rated yet |
0
Common food preservative may slow, even stop tumor growth
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Cancer
Oct 31, 2012 |
4.8 / 5 (6) |
0
|
